Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01724580
Expanded Access Status : No longer available
First Posted : November 12, 2012
Last Update Posted : November 18, 2020
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

Tracking Information
First Submitted Date November 5, 2012
First Posted Date November 12, 2012
Last Update Posted Date November 18, 2020
 
Descriptive Information
Brief Title Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Brief Summary The Requesting Physician/Investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.
Detailed Description Not Provided
Study Type Expanded Access
Intervention Drug: Baricitinib
Administered orally
Other Names:
  • LY3009104
  • INCB 028050
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Expanded Access Status No longer available
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United Kingdom,   United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT01724580
Responsible Party Eli Lilly and Company
Study Sponsor Eli Lilly and Company
Collaborators Not Provided
Investigators
Study Director: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) Eli Lilly and Company
PRS Account Eli Lilly and Company
Verification Date November 15, 2020